News
Home | News
WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers
May 23, 2024Photo caption (from left to right): Ms. Cindy Koh, Executive Vice President, Singapore Economic Development Board; Dr. Minzhang Chen, Co-CEO, WuXi AppTec; Mr. Heng Swee Keat, Deputy Prime Minister; Dr. Ge Li,…
2024 CDMO Leadership Awards
March 21, 2024Exciting moment! We’ve been honored with the 2024 CDMO Leadership Awards in all six core categories: Capabilities, Compatibility, Expertise, Quality, Reliability, and Service, again! Dr. Jinling Chen, our Senior Vice President and Head…
New Blow-Fill-Seal Aseptic Filling Line
January 31, 2024New Capability Spotlight: We just launched a new Blow-Fill-Seal (BFS) aseptic filling line at our drug product site in Wuxi City. Designed for eye drops and inhalants, this BFS line handles volumes…
New Continuous Hydrogenation Manufacturing Line
January 22, 2024Site Spotlight: We’ve just added two new continuous hydrogenation lines at our Changshu site, with a throughput of 200 kg/day. Our continuous hydrogenation process supports a wide range of reactions, including nitro…
WuXi AppTec Triples Peptide Manufacturing Capacity and Launches the New Taixing API Manufacturing Site
January 8, 2024Expansion Boosts Solid-Phase Peptide Synthesis Total Reactor Volume to 32,000 Liters in Response to Surging Demand Shanghai, China – January 8, 2024 — WuXi AppTec, a global company that provides a broad…
WuXi STA Debuts Its First High Potency Sterile Injectable Manufacturing Line at Wuxi City Site
July 17, 2023Shanghai, China, July 17, 2023 -- WuXi STA, a global Contract Research, Development, and Manufacturing Organization (CRDMO), today launched its first high potency (HP), fully automated sterile injectable manufacturing line at the…
